We are live on
!
Find out more
Adage Capital Partners Portfolio holdings
AUM
$64.8B
1-Year Est. Return
42.7%
This Fund
S&P 500
This Quarter
Est. Return
+9.27%
1 Year Est. Return
+42.7%
3 Year Est. Return
+139.29%
5 Year Est. Return
+204.38%
10 Year Est. Return
+879.75%
AUM
$49B
AUM Growth
+$3.11B
(+6.8%)
Cap. Flow
+$228M
Cap. Flow
% of AUM
0.47%
Top 10 Holdings %
Top 10 Hldgs %
21.37%
Holding
1,104
New
303
Increased
294
Reduced
324
Closed
153
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
GWPH
GW Pharmaceuticals Plc American Depositary Shares
GWPH
|
+$282M |
| 2 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$205M |
| 3 |
ConocoPhillips
COP
|
+$203M |
| 4 |
Fortive
FTV
|
+$200M |
| 5 |
Merck
MRK
|
+$178M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Royalty Pharma
RPRX
|
+$665M |
| 2 |
ExxonMobil
XOM
|
+$332M |
| 3 |
Burlington
BURL
|
+$242M |
| 4 |
National Vision
EYE
|
+$186M |
| 5 |
CXO
CONCHO RESOURCES INC.
CXO
|
+$175M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.67% |
| 2 | Healthcare | 17.99% |
| 3 | Financials | 14.03% |
| 4 | Consumer Discretionary | 11.97% |
| 5 | Communication Services | 8.59% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
376
Fortinet
FTNT
$117B
| $24.9M | 0.05% |
674,590
+48,500
| +8% | +$1.59M |
|
377
Inspire Medical Systems
INSP
$1.7B
| $24.8M | 0.05% |
120,000
+10,000
| +9% | +$2.13M |
|
378
NetApp
NTAP
$37.6B
| $24.4M | 0.05% |
335,900
+155,400
| +86% | +$10.4M |
|
379
Adient
ADNT
$1.48B
| $24.3M | 0.05% |
550,000
-119,761
| -18% | -$4.52M |
|
|
MUDS
380
DELISTED
Mudrick Capital Acquisition Corporation II Class A Common Stock
MUDS
| $24.3M | 0.05% |
+2,475,000
| New | +$24.9M |
|
381
McCormick & Company Non-Voting
MKC
$14.1B
| $24.2M | 0.05% |
270,930
-5,200
| -2% | -$463K |
|
382
Equifax
EFX
$20.7B
| $24.1M | 0.05% |
133,100
+1,000
| +0.8% | +$177K |
|
383
CarMax
KMX
$8.24B
| $24.1M | 0.05% |
181,700
+179,114
| +6,926% | +$21.8M |
|
384
RenaissanceRe
RNR
$13.4B
| $24M | 0.05% |
150,000
+20,000
| +15% | +$3.23M |
|
385
AerCap
AER
$24.4B
| $24M | 0.05% |
407,848
-823,777
| -67% | -$40.1M |
|
386
United Airlines
UAL
$41.9B
| $23.9M | 0.05% |
415,418
+60,900
| +17% | +$2.97M |
|
|
IMPX
387
DELISTED
AEA-Bridges Impact Corp
IMPX
| $23.9M | 0.05% |
2,432,309
-1,167,691
| -32% | -$12.2M |
|
388
Church & Dwight Co
CHD
$24.5B
| $23.7M | 0.05% |
270,774
-5,100
| -2% | -$426K |
|
389
Carnival Corporation Ltd
CCL
$39.4B
| $23.6M | 0.05% |
888,300
+66,800
| +8% | +$1.58M |
|
390
ResMed
RMD
$32.4B
| $23.5M | 0.05% |
121,169
-38,600
| -24% | -$7.74M |
|
|
UHG
391
DELISTED
United Homes Group
UHG
| $23.4M | 0.05% |
+2,400,000
| New | +$23.4M |
|
392
LyondellBasell Industries
LYB
$19.8B
| $23.3M | 0.05% |
224,400
+219,600
| +4,575% | +$21.8M |
|
393
Spyre Therapeutics
SYRE
$9.12B
| $23.3M | 0.05% |
117,926
-1,754
| -1% | -$337K |
|
394
Henry Schein
HSIC
$9.83B
| $23.3M | 0.05% |
337,000
+236,800
| +236% | +$16M |
|
395
ThredUp
TDUP
$401M
| $23.3M | 0.05% |
+1,000,000
| New | +$24.2M |
|
396
Enphase Energy
ENPH
$5.24B
| $23.3M | 0.05% |
+143,800
| New | +$25.8M |
|
397
Alexandria Real Estate Equities
ARE
$8.34B
| $23.3M | 0.05% |
141,600
+4,100
| +3% | +$683K |
|
398
Martin Marietta Materials
MLM
$32.3B
| $23.3M | 0.05% |
69,239
-82,676
| -54% | -$26.4M |
|
399
Oneok
OKE
$55.4B
| $23.2M | 0.05% |
458,400
-9,300
| -2% | -$423K |
|
400
Primoris Services
PRIM
$4.35B
| $23.2M | 0.05% |
+700,000
| New | +$23M |
|
Similar funds
Adage Capital Partners's Q1 2021 Portfolio in Review
As of Q1 2021, Adage Capital Partners held 1,104 positions worth $49B, up 6.8% from $45.9B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
Adage Capital Partners's Q1 2021 filing shows 303 new, 294 increased, 324 reduced and 153 closed positions. Its largest new stake was GW Pharmaceuticals Plc American Depositary Shares: 1,500,000 shares worth $325M. The largest sale was Royalty Pharma, an estimated $665M.
By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 21% a quarter earlier, followed by Healthcare and Financials.
- Adage Capital Partners's largest Q1 2021 buy was GW Pharmaceuticals Plc American Depositary Shares: 1,500,000 shares worth $325M.
- Adage Capital Partners added most to Alexion Pharmaceuticals in Q1 2021, an estimated $205M increase.
- Adage Capital Partners's biggest Q1 2021 reduction was Royalty Pharma, cutting an estimated $665M.
- Adage Capital Partners fully exited CONCHO RESOURCES INC. in Q1 2021, selling an estimated $175M.
- Adage Capital Partners's ten largest holdings make up 21% of its $49B portfolio in Q1 2021.
- Adage Capital Partners opened 303 new positions and closed 153 in Q1 2021.
- Adage Capital Partners's portfolio value rose 6.8% quarter-over-quarter to $49B.
Based on Adage Capital Partners's 13F filing for Q1 2021, filed 17 May 2021.